PD-1 blockade exploiting MMR deficiency – Nature.com
Nature.com |
PD-1 blockade exploiting MMR deficiency
Nature.com These tumours typically harbour thousands of mutations and are postulated to present neoantigens that might be exploited for effective immunotherapy. New data reported by Dung Le et al. support this hypothesis, underscoring MMR as a predictive … |
